Show
Sort by
-
Cytoreductive nephrectomy and exposure to sunitinib : a post hoc analysis of the immediate surgery or surgery after sunitinib malate in treating patients with metastatic kidney cancer (SURTIME) trial
-
Characterisation and classification of oligometastatic disease : a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
-
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials : recommendations of the SISAQOL Consortium
-
Towards an evidence-informed value scale for surgical and radiation oncology : a multi-stakeholder perspective
-
ESMO-MCBS : setting the record straight : authors' reply
-
Surgical safety of cytoreductive nephrectomy following sunitinib : results from the multicentre, randomised controlled trial of immediate versus deferred nephrectomy (SURTIME)
-
Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib : the SURTIME randomized clinical trial
-
Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer : a consensus recommendation from the EORTC Imaging Group
-
Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer : a systematic review
-
Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)